DAIS - Digital Archive of the Serbian Academy of Sciences and Arts
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrilic)
    • Serbian (Latin)
  • Login
View Item 
  •   DAIS
  • Институт техничких наука САНУ / Institute of Technical Sciences of SASA
  • ITN SANU - Opšta kolekcija / ITS SASA - General collection
  • View Item
  •   DAIS
  • Институт техничких наука САНУ / Institute of Technical Sciences of SASA
  • ITN SANU - Opšta kolekcija / ITS SASA - General collection
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats

Authorized Users Only
2018
Authors
Petrović, Daniela
Seke, Mariana
Labudović Borović, Milica
Jović, Danica
Borišev, Ivana
Srđenovic, Branislava
Rakočević, Zlatko
Pavlović, Vladimir B.
Đorđevic, Aleksandar
Article (Published version)
Metadata
Show full item record
Abstract
In our recent studies we have designed fullerenol/doxorubicin nanocomposite (FNP/DOX) as the new drug nanocarrier. This research has demonstrated that this novel nanocomposite has had better implications on the liver tissue in vivo (Wistar rats treated intraperitoneally), than treatment based only on DOX. FNP/DOX has been characterised by DLS, TEM and AFM measurements which have shown that DOX loaded onto FNP did not influence fullerenol nanoparticle's size. FNP/DOX affected oxidative status in blood causing a significant decrease of catalase and SOD activity in comparison to DOX, implicating the reduction in oxidative stress. qRT-PCR results on the mRNA level of antioxidative enzymes (catalase and MnSOD) revealed that the effect of oxidative stress is significantly reduced by the treatment with FNP/DOX (p <.05). The ultrastructural analysis of the liver tissue has revealed that FNP/DOX nanocomposite generated considerably less damage in the liver tissue, than DOX applied at the same d...ose. Hence, our results have indicated that FNP, within FNP/DOX nanocomposite, exhibits protective effects to the liver tissue of the healthy rats. © 2018

Keywords:
AFM / drug delivery / qRT-PCR / fullerenol/doxorubicin nanocomposite / ultrastructural analysis
Source:
Experimental and Molecular Pathology, 2018, 104, 3, 199-211
Publisher:
  • Elsevier
Projects:
  • Functional, Functionalized and Advanced Nanomaterials (RS-45005)

DOI: 10.1016/j.yexmp.2018.04.005

ISSN: 0014-4800

WoS: 000434907600005

Scopus: 2-s2.0-85046811167
[ Google Scholar ]
8
7
URI
http://dais.sanu.ac.rs/123456789/3755
Collections
  • ITN SANU - Opšta kolekcija / ITS SASA - General collection
Institution
Институт техничких наука САНУ / Institute of Technical Sciences of SASA
TY  - JOUR
AU  - Petrović, Daniela
AU  - Seke, Mariana
AU  - Labudović Borović, Milica
AU  - Jović, Danica
AU  - Borišev, Ivana
AU  - Srđenovic, Branislava
AU  - Rakočević, Zlatko
AU  - Pavlović, Vladimir B.
AU  - Đorđevic, Aleksandar
PY  - 2018
UR  - http://dais.sanu.ac.rs/123456789/3755
AB  - In our recent studies we have designed fullerenol/doxorubicin nanocomposite (FNP/DOX) as the new drug nanocarrier. This research has demonstrated that this novel nanocomposite has had better implications on the liver tissue in vivo (Wistar rats treated intraperitoneally), than treatment based only on DOX. FNP/DOX has been characterised by DLS, TEM and AFM measurements which have shown that DOX loaded onto FNP did not influence fullerenol nanoparticle's size. FNP/DOX affected oxidative status in blood causing a significant decrease of catalase and SOD activity in comparison to DOX, implicating the reduction in oxidative stress. qRT-PCR results on the mRNA level of antioxidative enzymes (catalase and MnSOD) revealed that the effect of oxidative stress is significantly reduced by the treatment with FNP/DOX (p <.05). The ultrastructural analysis of the liver tissue has revealed that FNP/DOX nanocomposite generated considerably less damage in the liver tissue, than DOX applied at the same dose. Hence, our results have indicated that FNP, within FNP/DOX nanocomposite, exhibits protective effects to the liver tissue of the healthy rats. © 2018
PB  - Elsevier
T2  - Experimental and Molecular Pathology
T1  - Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats
SP  - 199
EP  - 211
VL  - 104
IS  - 3
DO  - 10.1016/j.yexmp.2018.04.005
ER  - 
@article{
author = "Petrović, Daniela and Seke, Mariana and Labudović Borović, Milica and Jović, Danica and Borišev, Ivana and Srđenovic, Branislava and Rakočević, Zlatko and Pavlović, Vladimir B. and Đorđevic, Aleksandar",
year = "2018",
url = "http://dais.sanu.ac.rs/123456789/3755",
abstract = "In our recent studies we have designed fullerenol/doxorubicin nanocomposite (FNP/DOX) as the new drug nanocarrier. This research has demonstrated that this novel nanocomposite has had better implications on the liver tissue in vivo (Wistar rats treated intraperitoneally), than treatment based only on DOX. FNP/DOX has been characterised by DLS, TEM and AFM measurements which have shown that DOX loaded onto FNP did not influence fullerenol nanoparticle's size. FNP/DOX affected oxidative status in blood causing a significant decrease of catalase and SOD activity in comparison to DOX, implicating the reduction in oxidative stress. qRT-PCR results on the mRNA level of antioxidative enzymes (catalase and MnSOD) revealed that the effect of oxidative stress is significantly reduced by the treatment with FNP/DOX (p <.05). The ultrastructural analysis of the liver tissue has revealed that FNP/DOX nanocomposite generated considerably less damage in the liver tissue, than DOX applied at the same dose. Hence, our results have indicated that FNP, within FNP/DOX nanocomposite, exhibits protective effects to the liver tissue of the healthy rats. © 2018",
publisher = "Elsevier",
journal = "Experimental and Molecular Pathology",
title = "Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats",
pages = "199-211",
volume = "104",
number = "3",
doi = "10.1016/j.yexmp.2018.04.005"
}
Petrović D, Seke M, Labudović Borović M, Jović D, Borišev I, Srđenovic B, Rakočević Z, Pavlović VB, Đorđevic A. Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats. Experimental and Molecular Pathology. 2018;104(3):199-211
Petrović, D., Seke, M., Labudović Borović, M., Jović, D., Borišev, I., Srđenovic, B., Rakočević, Z., Pavlović, V. B.,& Đorđevic, A. (2018). Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats.
Experimental and Molecular PathologyElsevier., 104(3), 199-211. 
https://doi.org/10.1016/j.yexmp.2018.04.005
Petrović Daniela, Seke Mariana, Labudović Borović Milica, Jović Danica, Borišev Ivana, Srđenovic Branislava, Rakočević Zlatko, Pavlović Vladimir B., Đorđevic Aleksandar, "Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats" 104, no. 3 (2018):199-211,
https://doi.org/10.1016/j.yexmp.2018.04.005 .

DSpace software copyright © 2002-2015  DuraSpace
About DAIS - Digital Archive of the Serbian Academy of Sciences and Arts | Send Feedback

re3dataOpenAIRERCUB
 

 

All of DSpaceInstitutionsAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About DAIS - Digital Archive of the Serbian Academy of Sciences and Arts | Send Feedback

re3dataOpenAIRERCUB